Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01151605 · ClinicalTrials.gov registry record · NA
The Suppression of Toll Like Receptors by Insulin
A NA study, sponsored by University at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01151605 is a NA study that has completed, run by University at Buffalo. The registered enrollment target is 30 participants.
The verdict
NCT01151605, a NA study, has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will help us understand the possible beneficial effects of insulin in inflammation. Inflamamtion is considered to be the cause of atherosclerosis and heart disease.
Interventions
- DRUG insulin infusion
- DRUG Dextrose infusion
- DRUG Saline Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01151605
The ClinicalTrials.gov registry entry for NCT01151605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which insulin infusion is the first listed.
NCT01151605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01151605 about?
NCT01151605 is a clinical study titled "The Suppression of Toll Like Receptors by Insulin". This study will help us understand the possible beneficial effects of insulin in inflammation. Inflamamtion is considered to be the cause of atherosclerosis and heart disease.
What is the current status of trial NCT01151605?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2008-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01151605?
The interventions under investigation include: insulin infusion (DRUG), Dextrose infusion (DRUG), Saline Infusion (DRUG).
Who is sponsoring clinical trial NCT01151605?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.